A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva weighs potential sale of its $2B API business: reports
Teva seeking to acquire drug manufacturer Mylan for $40 billion
Teva to pay $225M to settle cholesterol drug price-fixing charges - ABC News
Drug maker Teva agrees to $4.3 billion national settlement over opioid lawsuits - MarketWatch
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Malta - Did you know that Teva Pharmaceutical Industries is one of the largest pharmaceutical companies globally? 🌎 We have 60 manufacturing sites all over the world, and an expert team
PharmaBoardroom - TEVA
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
FDA confirms shortage of Adderall, with delays possible until end of year
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Teva | Contract Pharma
Amid US drug shortages, Teva plots cuts to its generics portfolio
Opioid manufacturer Teva Pharmaceuticals announces $523M settlement with New York state - JURIST - News
How a Teva-Mylan deal will affect Indian pharma companies | Mint
Teva Pharmaceutical Industries - extension | Building Projects Group Ltd.
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
